We are live on ! Find out more
HHGC

Hunting Hill Global Capital Portfolio holdings

AUM $129M
1-Year Est. Return 17.34%
This Fund
S&P 500
This Quarter Est. Return
+12.14%
1 Year Est. Return
+17.34%
3 Year Est. Return
+131.73%
5 Year Est. Return
+192.58%
10 Year Est. Return
AUM
$446M
AUM Growth
+$46.6M
Cap. Flow
+$4.89M
Cap. Flow %
1.1%
Top 10 Hldgs %
82.88%
Holding
31
New
12
Increased
5
Reduced
4
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 16.52%
2 Financials 6.1%
3 Technology 5.24%
4 Consumer Discretionary 2%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
1
PUT
DELISTED
Allergan plc
AGN
$76.5M 17.14%
400,000
-50,000
-11% -$9.02M
AGN
2
DELISTED
Allergan plc
AGN
$68.3M 15.31%
357,300
FXI icon
3
iShares China Large-Cap ETF
FXI
$4.27B
$59.3M 13.31%
1,360,279
+844,841
+164% +$35.2M
WCG
4
DELISTED
Wellcare Health Plans, Inc.
WCG
$37.1M 8.32%
112,384
+86,284
+331% +$25.9M
AMTD
5
DELISTED
TD Ameritrade Holding Corp
AMTD
$27M 6.05%
+543,229
New +$23.5M
TIF
6
PUT
DELISTED
Tiffany & Co.
TIF
$26.7M 5.99%
+200,000
New +$23.6M
CEF icon
7
Sprott Physical Gold and Silver Trust
CEF
$7.35B
$24.1M 5.41%
1,646,549
+351,786
+27% +$5.04M
MLNX
8
DELISTED
Mellanox Technologies, Ltd.
MLNX
$21.3M 4.78%
181,876
-122,724
-40% -$13.9M
EWH icon
9
iShares MSCI Hong Kong ETF
EWH
$1.24B
$17.8M 3.98%
730,335
VVR icon
10
Invesco Senior Income Trust
VVR
$454M
$11.5M 2.57%
2,676,771
-1,147,977
-30% -$4.79M
EWM icon
11
iShares MSCI Malaysia ETF
EWM
$309M
$10.8M 2.43%
380,000
+180,000
+90% +$5.04M
BABA icon
12
Alibaba
BABA
$276B
$8.93M 2%
+42,121
New +$7.9M
VTA
13
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$7.89M 1.77%
694,918
-338,758
-33% -$3.75M
TIF
14
DELISTED
Tiffany & Co.
TIF
$7.72M 1.73%
+57,778
New +$6.83M
FOX icon
15
Fox Class B
FOX
$21.7B
$7.28M 1.63%
+200,000
New +$6.72M
RARX
16
PUT
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$6.73M 1.51%
+143,400
New +$6.34M
ASHR icon
17
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$6.14M 1.38%
+207,280
New +$5.84M
TAK icon
18
Takeda Pharmaceutical
TAK
$56B
$5.4M 1.21%
273,772
EPHE icon
19
iShares MSCI Philippines ETF
EPHE
$132M
$5.15M 1.15%
+150,000
New +$5.17M
PE
20
DELISTED
PARSLEY ENERGY INC
PE
$3.38M 0.76%
+178,800
New +$2.95M
SPY icon
21
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$2.7M 0.61%
+8,400
New +$2.59M
HPQ icon
22
HP
HPQ
$25.9B
$2.08M 0.47%
+101,100
New +$1.92M
KBA icon
23
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
$1.6M 0.36%
49,029
+1,518
+3% +$47.4K
PHYS icon
24
Sprott Physical Gold
PHYS
$14.5B
$334K 0.07%
+27,456
New +$327K
MFC icon
25
Manulife Financial
MFC
$74.2B
$200K 0.04%
10,000

Similar funds

Hunting Hill Global Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Hunting Hill Global Capital held 31 positions worth $446M, up 12% from $399M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Hunting Hill Global Capital's Q4 2019 filing shows 12 new, 5 increased, 4 reduced and 6 closed positions. Its largest new stake was TD Ameritrade Holding Corp: 543,229 shares worth $27M. The largest sale was Celgene Corp, an estimated $59.9M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 31% a quarter earlier, followed by Financials and Technology.

  • Hunting Hill Global Capital's largest Q4 2019 buy was TD Ameritrade Holding Corp: 543,229 shares worth $27M.
  • Hunting Hill Global Capital added most to iShares China Large-Cap ETF in Q4 2019, an estimated $35.2M increase.
  • Hunting Hill Global Capital's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $13.9M.
  • Hunting Hill Global Capital fully exited Celgene Corp in Q4 2019, selling an estimated $59.9M.
  • Hunting Hill Global Capital's ten largest holdings make up 83% of its $446M portfolio in Q4 2019.
  • Hunting Hill Global Capital opened 12 new positions and closed 6 in Q4 2019.
  • Hunting Hill Global Capital's portfolio value rose 12% quarter-over-quarter to $446M.

Based on Hunting Hill Global Capital's 13F filing for Q4 2019, filed 14 Feb 2020.